Ataxin 3 anticorps (AA 1-215)
Aperçu rapide pour Ataxin 3 anticorps (AA 1-215) (ABIN1885789)
Antigène
Voir toutes Ataxin 3 (ATXN3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-215
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 215 of Ataxin 3
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 20 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- Ataxin 3 (ATXN3)
-
Autre désignation
- Ataxin 3
-
Sujet
-
Machado-Joseph disease, also known as spinocerebellar ataxia-3, is an autosomal dominant neurologic disorder.The protein encoded by this gene contains (CAG)n repeats in the coding region, and the expansion of these repeats from the normal 13-36 to 68-79 is the cause of Machado-Joseph disease.There is a negative correlation between the age of onset and CAG repeat numbers.Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq]
-
Poids moléculaire
- 42 kDa
-
ID gène
- 4287
Antigène
-